Curaleaf Holdings, Inc. CURLF
—
11.07
(0.15)
(1.34%)
as of 25 Sep
- Market cap
- —
- P/E
- 0.0×
Follow CURLF
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
2.16 | 1.29 | 1.51 | 1.69 | |
P/FCF ratio |
38.04 | 29.97 | 26.04 | 30.02 | |
P/Operating CF |
97.20 | 79.06 | 45.37 | 44.08 | |
P/B ratio |
3.28 | 2.02 | 2.54 | 2.41 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
2.79 | 1.89 | 2.12 | 2.29 | |
EV/EBITDA |
15.96 | 10.43 | 11.12 | 11.31 | |
EV/Operating CF |
26.00 | 20.16 | 19.51 | 19.81 | |
EV/FCF |
49.04 | 43.79 | 36.43 | 40.59 | |
Quick Ratio |
0.59 | 0.60 | 0.60 | 0.59 | |
Current Ratio |
1.52 | 1.56 | 1.52 | 1.47 | |
Net Debt/EBITDA |
14.20 | 14.31 | 13.10 | 12.56 | |
Debt/Assets |
32.99% | 30.98% | 30.49% | 29.77% | |
Debt/Equity |
1.07 | 1.06 | 1.15 | 0.97 | |
Asset Turnover |
0.46 | 0.45 | 0.44 | 0.42 | |
Operating CF/Net income |
2.34 | 0.30 | (0.71) | (0.85) | |
Capex/Depreciation |
(0.30) | (0.32) | (0.31) | (0.30) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
38.72% | 37.90% | 36.75% | 37.62% | |
Intangible Assets out of Total Assets |
0.56 | 0.57 | 0.58 | 0.58 | |
Share Based Compensation of Revenue |
3.08% | 2.98% | 3.73% | 3.21% | |
Graham Net Nets |
(0.52) | (0.92) | (0.85) | (0.73) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(1.20%) | (6.07%) | (11.90%) | (11.47%) | |
Free Cash Flow Yield |
2.63% | 3.34% | 3.84% | 3.33% | |
Revenue per Share |
1.29 | 1.25 | 1.30 | 1.26 | |
Operating CF per Share |
0.11 | 0.08 | 0.17 | 0.19 | |
Capex per Share |
(0.06) | (0.07) | (0.06) | (0.07) | |
Free Cash Flow per Share |
0.05 | 0.02 | 0.10 | 0.12 | |
Cash per Share |
0.41 | 0.41 | 0.40 | 0.42 | |
Shareholders Equity per Share |
3.30 | 3.18 | 2.98 | 3.48 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
3.30 | 3.18 | 2.98 | 3.48 | |
Free Cash Flow |
13.10 | 3.94 | 25.95 | 31.76 | |
Working Capital |
160.68 | 165.17 | 154.31 | 141.01 | |
Capital Expenditures |
(16.16) | (17.05) | (16.38) | (16.65) | |
Net Current Asset Value |
(1,479.10) | (1,528.95) | (1,640.34) | (1,557.03) | |
EV/EBIT |
247.44 | 143.97 | 105.55 | 193.49 | |
Capex to Sales |
0.05 | 0.05 | 0.05 | 0.05 | |
Net Profit Margin |
3.68% | 21.53% | (18.09%) | (17.81%) | |
Price to Operating Income |
191.98 | 98.55 | 75.45 | 143.12 | |
| Other line items | |||||
Average Receivables |
72.44 | 68.41 | 71.19 | 68.38 | |
Average Payables |
63.17 | 75.27 | 76.93 | 71.88 | |
Average Inventory |
235.63 | 233.26 | 220.98 | 228.15 | |
Average Assets |
2,865.58 | 2,879.50 | 2,897.51 | 2,978.94 | |
Average Common Equity |
869.38 | 817.57 | 808.78 | 922.58 |
Columns are period end dates